Description

Ganciclovir Film-Coated Tablets (250 mg / 500 mg)

Healthy Inc is a specialized global supplier and exporter of advanced high-containment antivirals, immunology, and transplant-support therapeutics. We provide ultra-high-purity, kinetically stabilized Ganciclovir Film-Coated Tablets (250 mg / 500 mg), manufactured in WHO–GMP certified, strictly segregated high-containment (OEB 4) oral solid dosage facilities. This “Viral DNA Polymerase Inhibitor” is a massive-volume, highly critical export to organ transplant centers, major infectious disease NGOs, HIV/AIDS treatment networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated intervention for the prevention and maintenance treatment of Cytomegalovirus (CMV) retinitis and systemic CMV disease in profoundly immunocompromised patients.

Product Overview

This highly advanced formulation operates as a biochemical “Trojan Horse” specifically designed to eradicate Cytomegalovirus. It remains inactive in healthy human cells but becomes a lethal DNA-shredding weapon the moment it encounters the enzymes produced by the CMV virus, halting severe organ damage and preventing permanent blindness.

The “UL97 Kinase Activator & CMV Eradicator” Specialist:

• Mechanism 1 (The Viral Activation Sequence): Ganciclovir is a synthetic guanine derivative, but it is administered as a prodrug. To become active, it must be chemically altered (phosphorylated). Brilliantly, the drug relies on a specific enzyme produced only by the Cytomegalovirus itself—the UL97 viral kinase. This viral enzyme converts Ganciclovir into its monophosphate form, which cellular enzymes then convert into the highly toxic Ganciclovir Triphosphate. This ensures the drug concentrates its lethal effects specifically within infected cells.
• Mechanism 2 (The DNA Chain Termination): Once fully activated, Ganciclovir Triphosphate violently attacks the CMV DNA polymerase. When the virus attempts to build a new DNA chain to replicate itself, it mistakenly incorporates the Ganciclovir molecule. Because Ganciclovir lacks a vital chemical hook, the DNA chain physically cannot continue. Replication is instantly and permanently terminated.
• The “Transplant & HIV Lifeline” Paradigm: In healthy individuals, CMV is harmless. In a patient who just received a kidney transplant (and is taking heavy immunosuppressants), or a patient with advanced AIDS, CMV will rapidly destroy the retinas (causing blindness), the colon, and the lungs. Oral Ganciclovir is heavily procured by government tenders to provide crucial, long-term maintenance suppression following acute IV therapy, keeping these highly vulnerable patients alive and out of the ICU.

Product Composition & Strength

We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.

*Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• OEB 4 High-Containment & Cytotoxic Handling (CRITICAL COMPLIANCE): Ganciclovir is not a standard antiviral; it is a highly potent, DNA-altering compound considered to be a potential human carcinogen and teratogen. Manufacturing this compound in standard generic facilities is strictly prohibited. Our production takes place in dedicated High-Containment Isolator blocks (OEB 4) equipped with terminal HEPA filtration and closed-loop granulation. Furthermore, our heavy film-coating completely seals the active core, ensuring that nurses and patients are not exposed to aerosolized toxic particles during routine administration.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized management of life-threatening viral infections in immunocompromised patients:

• CMV Retinitis (HIV/AIDS): Maintenance treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, particularly those with advanced HIV/AIDS, to prevent permanent blindness.
• CMV Prophylaxis (Transplant): Prevention of CMV disease in solid organ transplant recipients and individuals with advanced immunosuppression at high risk for CMV infection.

Dosage & Administration

Recommended Dosage (Strictly as per Infectious Disease / Transplant Guidelines):

• CMV Maintenance: Typically requires massive oral dosing due to lower bioavailability, often 1000 mg (two 500mg tablets) taken 3 times a day.
• Administration (The Mealtime Rule): Tablets MUST be administered with food. Taking Ganciclovir with a high-fat meal drastically increases its systemic absorption and bioavailability.
• Renal Dose Adjustment: Ganciclovir is cleared entirely by the kidneys. If a transplant patient has declining kidney function, the dose must be strictly and immediately reduced to prevent fatal drug accumulation.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Severe Hematologic Toxicity): Ganciclovir is intensely toxic to the bone marrow. It frequently causes severe, life-threatening leukopenia, neutropenia, anemia, and thrombocytopenia. Strict Complete Blood Counts (CBC) are mandatory every 2 weeks. The drug must be halted if absolute neutrophil counts (ANC) drop below 500 cells/μL.
• BLACK BOX WARNING (Carcinogenesis & Mutagenesis): Animal studies show Ganciclovir causes severe birth defects and cancer. It must be handled as a cytotoxic drug.
• BLACK BOX WARNING (Impairment of Fertility): Ganciclovir causes temporary or permanent inhibition of spermatogenesis in men and suppression of fertility in women.
• Embryo-Fetal Toxicity (Teratogenic): Highly effective contraception must be utilized by both men and women during therapy and for at least 90 days following the cessation of the drug.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Transplant/Infectious Disease Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antivirals, Cytotoxics, and OEB 4 High-Containment Formulations. Whether you are looking for a reliable Government Tender Supplier for national HIV/AIDS programs in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.